• Discreet packaging
  • Results 24-48h
  • Home delivery and collection
  • No appointments, no waiting
  • Accredited laboratories
  • Discreet packaging
  • Results 24-48h
  • Home delivery and collection
  • No appointments, no waiting
  • Accredited laboratories
  • Discreet packaging
  • Results 24-48h
  • Home delivery and collection
  • No appointments, no waiting
  • Accredited laboratories
  • Discreet packaging
  • Results 24-48h
  • Home delivery and collection
  • No appointments, no waiting
  • Accredited laboratories
Our Tests
For professionals
Activate Kit

PUBLIC HEALTH SOLUTIONS

Scale your screening programmes without cluttering the system

Let's talk about your programme
ap-hp 1
ffrd 1
community-madrid 1
erasmus-mc 1
h2
ffrd-2
community-madrid-2
erasmus-mc-2

Real impact on quality of life with early diagnosis

Deploys early detection programmes at scale with self-test kits, automated patient management and linkage to the healthcare professional; generating positive impact and reducing costs.

Improve the health indicators of the population by acting before pathologies become chronic.

Run mass campaigns with full security and traceability of results

Anticipate with early diagnosis to reduce the burden on the health care system

It frees health professionals to focus on the cases that matter.

Ensures equal access to early, innovative and safe diagnostics

DIAGNOSTICS AS A SERVICE

Comprehensive diagnostic solutions in a single ecosystem

Evidence accessible from anywhere

CE and IVD marked kits designed for easy and guided sampling. We take care of collection, shipment to the laboratory, analysis and interpretation of results.

Scientific rigour in every analysis

Samples are analysed in certified laboratories in our network. We integrate with new laboratories and health systems following health interoperability standards.

Accompanying the patient every step of the way

The patient is guided at all times by our app: kit activation, sample collection and access to results with an experience designed to understand their health in a clear way.

Simple clinical management at scale

Platform designed to scale patient management and personalised report delivery, keeping clinical control in the hands of the clinician at all times

AI trained by and for doctors

An artificial intelligence layer created in conjunction with physicians that converts lab data into structured clinical reports, ready for medical review.

Real-time health evidence

Anonymised results turned into population and longitudinal health analytics to improve prevention, research and decision making with our network of partners

Ready-to-integrate tests

Type 1 diabetes

What we measure
  • HbA1c
  • IAA
  • GADA
  • IA-2A
  • ZnT8A

More information

Cardiovascular monitoring

What we measure
  • Lp(a)
  • LDL
  • HDL
  • Triglycerides
  • 1 more

More information

Renal profile

What we measure
  • Glomerular Filtration
  • Creatinine
  • Albumin

More information

Design your solution with Ailin today

Type 1 diabetes

  • Family background
  • Autoimmune diseases

We assess the risk of developing type 1 diabetes (T1D) by measuring the main associated autoantibodies and glycaemic profile, using a minimally invasive capillary finger prick test, both inside and outside the clinical setting.

It allows the implementation of screening campaigns in populations at higher risk of T1D, including first-degree relatives and people with associated autoimmunity.

In addition, analysis of multiple autoantibodies and metabolic biomarkers allows segmentation of risk populations and the generation of real-world evidence (RWE) in longitudinal cohorts across successive programmes.

  • Minimally invasive tests
  • Structured consent management and traceability
  • Results in 7-14 days
  • Clinical interpretation included
  • Digital platform ready to integrate
Request for information

Cardiovascular monitoring

  • Family background
  • Cardiometabolic health

We assess cardiovascular risk by determining the main lipid biomarkers (total cholesterol, HDL, LDL and triglycerides) and Lp(a), using a minimally invasive capillary finger prick test, both inside and outside the clinical setting.

It allows the implementation of screening campaigns in populations at increased cardiometabolic risk, including people with a family history and/or associated risk factors.

The combined analysis of lipid biomarkers and Lp(a) facilitates risk stratification and the generation of real-world evidence (RWE) in population-based cohorts through successive programmes.

  • Minimally invasive tests
  • Structured consent management and traceability
  • Results in 5-7 days
  • Clinical interpretation included
  • Digital platform ready to integrate
Request for information

Renal profile

  • Family background
  • Diabetes

Chronic kidney disease (CKD) can progress silently for years, making early detection key. Our programmes assess kidney function by determining key biomarkers - creatinine, glomerular filtration rate, and albumin/creatinine ratio - through a minimally invasive test using capillary puncture and urine sampling, both inside and outside the clinical setting.

It allows screening campaigns to be implemented in populations at higher risk of CKD, including people with diabetes, hypertension, cardiovascular disease or those over 60 years of age.

Structured analysis of renal biomarkers allows the generation of aggregated population screening data and enables longitudinal follow-up tools, facilitating the evaluation of the impact of early detection programmes.

  • Minimally invasive tests
  • Structured consent management and traceability
  • Results in 5 days
  • Clinical interpretation included
  • Digital platform ready to integrate
Request for information

Account

Explore

Whatsapp Instagram Linkedin Youtube
Why do we include it in this test?

 .

What other tests are you undergoing?
Discount coupon of 5% available: #ADS05
10% discount coupon available: AILINSOCIAL